Cargando…

Repurposing metformin for cancer treatment: current clinical studies

In recent years, several studies have presented evidence suggesting a potential role for metformin in anti-cancer therapy. Preclinical studies have demonstrated several anticancer molecular mechanisms of metformin including mTOR inhibition, cytotoxic effects, and immunomodulation. Epidemiologic data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chae, Young Kwang, Arya, Ayush, Malecek, Mary-Kate, Shin, Daniel Sanghoon, Carneiro, Benedito, Chandra, Sunandana, Kaplan, Jason, Kalyan, Aparna, Altman, Jessica K., Platanias, Leonidas, Giles, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130043/ https://www.ncbi.nlm.nih.gov/pubmed/27004404 http://dx.doi.org/10.18632/oncotarget.8194

Ejemplares similares

Genomic landscape of DNA repair genes in cancer
por: Chae, Young Kwang, et al.
Publicado: (2016)

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
por: Chae, Young Kwang, et al.
Publicado: (2016)

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling
por: Chae, Young Kwang, et al.
Publicado: (2015)

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
por: Chae, Young Kwang, et al.
Publicado: (2018)

The challenge of developmental therapeutics for adrenocortical carcinoma
por: Costa, Ricardo, et al.
Publicado: (2016)

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives
por: Costa, Ricardo, et al.
Publicado: (2016)

FGFR3-TACC3 fusion in solid tumors: mini review
por: Costa, Ricardo, et al.
Publicado: (2016)

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
por: Mota, Jose Mauricio, et al.
Publicado: (2017)

Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
por: Kaplan, Jason B., et al.
Publicado: (2016)

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
por: Chae, Young Kwang, et al.
Publicado: (2016)

Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature review
por: Chae, Young Kwang, et al.
Publicado: (2017)

Repurposing Metformin for Vascular Disease
por: Triggle, Chris R., et al.
Publicado: (2023)

Repurposing metformin for the treatment of gastrointestinal cancer
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021)

Targeting mTOR for the treatment of AML. New agents and new directions
por: Altman, Jessica K., et al.
Publicado: (2011)

Wnt/beta-catenin pathway: modulating anticancer immune response
por: Pai, Sachin Gopalkrishna, et al.
Publicado: (2017)

Metformin: update on mechanisms of action and repurposing potential
por: Foretz, Marc, et al.
Publicado: (2023)

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
por: Chuzi, Sarah, et al.
Publicado: (2017)

Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemias
por: Curi, Dany A., et al.
Publicado: (2015)

Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinase
por: Colamonici, Marco, et al.
Publicado: (2015)

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
por: Agostini, Francesco, et al.
Publicado: (2021)

The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
por: Papadakos, Stavros P., et al.
Publicado: (2023)

Repurposing metformin as a quorum sensing inhibitor in Pseudomonas aeruginosa
por: Abbas, Hisham A, et al.
Publicado: (2017)

Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
por: Lord, Simon R., et al.
Publicado: (2023)

Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
por: Hua, Yu, et al.
Publicado: (2023)

Regulatory Effects of Sestrin 3 (SESN3) in BCR-ABL Expressing Cells
por: Vakana, Eliza, et al.
Publicado: (2013)

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions
por: Costa, Ricardo, et al.
Publicado: (2016)

Repurposing metformin: an old drug with new tricks in its binding pockets
por: Pryor, Rosina, et al.
Publicado: (2015)

Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota
por: Isnard, Stéphane, et al.
Publicado: (2020)

Analyses of selected safety endpoints in phase 1 and late-phase clinical trials of anti-PD-1 and PD-L1 inhibitors: prediction of immune-related toxicities
por: Costa, Ricardo, et al.
Publicado: (2017)

Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury
por: El-Rashid, Maryam, et al.
Publicado: (2020)

Synthesis and Characterization of Lipophilic Salts of Metformin to Improve Its Repurposing for Cancer Therapy
por: Saeed, Hiwa K., et al.
Publicado: (2021)

Modulation of autophagy, apoptosis and oxidative stress: a clue for repurposing metformin in photoaging
por: Mostafa, Dalia Kamal, et al.
Publicado: (2022)

Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells
por: Shah, Chirag A., et al.
Publicado: (2016)

AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications
por: Vakana, Eliza, et al.
Publicado: (2011)

ULK1 in type I interferon response
por: Saleiro, Diana, et al.
Publicado: (2015)

MNK Proteins as Therapeutic Targets in Leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
por: Eckerdt, Frank, et al.
Publicado: (2023)

Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?
por: Chae, Young Kwang, et al.
Publicado: (2017)

Repurposing Metformin for periodontal disease management as a form of oral-systemic preventive medicine
por: Neves, Vitor C. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_evct0dhhvjojjba5vp0lfh4psp